We are live on ! Find out more
BLFS icon

BioLife Solutions

80 hedge funds and large institutions have $168M invested in BioLife Solutions in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 16

0% more funds holding

Funds holding: 8080 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

0.32% less ownership

Funds ownership: 50.36%50.04% (-0.32%)

2% less capital invested

Capital invested by funds: $170M → $168M (-$2.87M)

59% less call options, than puts

Call options by funds: $179K | Put options by funds: $437K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
80
Holders Change
Holders Change %
0%
% of All Funds
1.58%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
10
Increased
42
Reduced
16
Closed
10
Calls
$179K
Puts
$437K
Net Calls
-$258K
Net Calls Change
+$183K

BLFS Hedge Fund Activity: Q4 2019 in Review

80 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2019, worth a combined $168M — down 1.7% from $170M a quarter earlier.

Fund positioning in BLFS was balanced in Q4 2019: 10 funds opened new positions, 10 closed out, 42 added to existing stakes and 16 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $1.32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $2.49M sold.

  • 80 institutional investors held BioLife Solutions (BLFS) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $168M of BioLife Solutions stock for Q4 2019, down 1.7% quarter-over-quarter.
  • 10 funds opened new BioLife Solutions positions in Q4 2019 and 10 closed out, a net change of 0 holders.
  • The largest BioLife Solutions buyer in Q4 2019 was Park West Asset Management, an estimated $1.32M added.
  • The largest BioLife Solutions seller in Q4 2019 was Fidelity Investments, an estimated $2.49M sold.

Based on aggregated 13F filings for Q4 2019.